nathalie baye died on Friday evening after suffering from Lewy body disease, a neurodegenerative illness that is less widely known than Parkinson’s or Alzheimer’s but is described as common. The condition mainly affects older people and is now drawing fresh attention because of her death at the age of 77. France Alzheimer says the disease is the second leading cause of degenerative cognitive disorders after Alzheimer’s.
The illness that affected nathalie baye
Lewy body disease is marked by abnormal protein deposits that build up inside brain cells and disrupt the messages the brain sends. France Alzheimer says the disease can cause mood changes, hallucinations and movement disorders, and there is currently no specific curative treatment.
In France, nearly 250, 000 people are believed to live with the disease, and average life expectancy after diagnosis is five to eight years. Its symptoms can resemble those of Parkinson’s and Alzheimer’s, which can make recognition difficult and delay understanding of what is happening to the patient.
What her death puts back in focus
nathalie baye had already brought the issue of end-of-life suffering into public debate in 2023, when she appeared on the front page of a magazine linked to a collective appeal by 109 public figures urging Emmanuel Macron to change the law on end of life. The debate remains under discussion in Parliament.
In a March 2023 interview published in connection with that campaign, she said she saw no point in prolonging suffering and added that if she ever found herself in that state, she would want life to be stopped. Her words now return with added force as her death places the illness and the limits of treatment back at the center of public conversation.
Why the disease is so often overlooked
France Alzheimer describes Lewy body disease as little known despite being frequent, especially among older adults. That gap matters because the illness combines cognitive, mood and motor symptoms, creating a difficult path for patients and families trying to understand the progression.
Other public figures have also faced the disease, including Robin Williams before his death in 2014 and Catherine Laborde, who died in January 2025. Their cases, together with nathalie baye’s death, underline how often the condition appears in the lives of well-known figures even as it remains unfamiliar to many people.
What comes next
The immediate effect of nathalie baye’s death is likely to be renewed public attention on a disorder that many people still do not recognize by name. It may also sharpen interest in the ongoing parliamentary debate over end of life, especially for patients facing severe and incurable illness. For now, the key facts remain clear: nathalie baye died after living with a disease that has no specific curative treatment and continues to affect thousands of families across France.
